Editorial Board — Medscape Pulmonary Medicine
James F. Donohue, MD
Professor, Emeritus Division Chief, University of North Carolina School of Medicine; Professor, Department of Pulmonary Medicine/Critical Care, University of North Caroline Health Chapel Hill, North Carolina
James F. Donohue, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor or consultant for: AstraZeneca; GlaxoSmithKline; Mylan; Sonovian; Novartis; Theravance
Serve(d) as a speaker for: GlaxoSmithKline
Received income in an amount equal to or greater than $250 from: AstraZeneca; GlaxoSmithKline; Mylan; Sonovian; Novartis; Theravance
Aaron B. Holley, MD
Associate Professor, Department of Medicine, Uniformed Services University (USU); Program Director, Pulmonary and Critical Care Medical Fellowship, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland
Aaron B. Holley, MD, has disclosed the following relevant financial relationships:
Writes guidelines and publishes literature for: CHEST College
Received income in an amount equal to or greater than $250 from: CHEST College
Steven Nathan, MD
Professor of Medicine, Virginia Commonwealth University; Medical Director, Advanced Lung Disease Center, Inova Fairfax Hospital, Falls Church, Virginia
Steven D. Nathan, MD, has disclosed the following relevant financial relationships:
Serve(d) as an advisor for: Boehringer-Ingelheim Pharmaceuticals, Inc.; Roche-Genentech; Bellerophon; United Therapeutics Corporation
Serve(d) as a speaker or a member of a speakers bureau for: Boehringer-Ingelheim Pharmaceuticals; Genentech; Gilead Sciences, Inc.
Received research grant from: Genentech; United Therapeutics Corporation